Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted benzopyrans as selective estrogen receptor-beta agonists

Substituted benzopyrans as selective estrogen receptor-beta agonists

US Patent 7354951 · Granted Apr 8, 2008

Estimated economic value: $129,752,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds useful for inhibiting RORγt2021
Compounds useful for inhibiting ROR-gamma-t2020
Dihydropyrido pyrimidine compounds as autotaxin inhibitors2017
Imidazo pyridine compounds2016
Bicyclic pyrimidine compounds2015
Imidazole derivatives useful for the treatment of arthritis2014
Selective estrogen receptor modulator for the treatment of osteoarthritis2013
Substituted tetralins as selective estrogen receptor-β agonists2012
Substituted benzopyrans as selective estrogen receptor-beta agonists2010
Substituted benzopyrans as selective estrogen receptor-beta agonists2010
Substituted benzopyrans as selective estrogen receptor-beta agonists2009
Substituted benzopyrans as selective estrogen receptor-beta agonists2009